Export 2631 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., R Allingham, R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., VanVeldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L., Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma., PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
H. E. Wiley, Thompson, D. J. S., Bailey, C., Chew, E. Y., Cukras, C. A., Jaffe, G. J., Lee, R. W. J., Loken, E. K., Meyerle, C. B., Wong, W., and Ferris, F. L., A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema., Ophthalmology, vol. 123, no. 4, pp. 841-9, 2016.
H. Wiley, Bailey, C., Cukras, C., Jaffe, G., Lee, R., Loken, E., Meyerle, C., Thompson, D., Wong, W., and Ferris, F., A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema, in 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), Denver, CO, 2015.
A. D. Williams, Kanner, J., Grantz, K. L., Ouidir, M., Sheehy, S., Sherman, S., Robledo, C., and Mendola, P., Air pollution exposure and risk of adverse obstetric and neonatal outcomes among women with type 1 diabetes., Environ Res, vol. 197, p. 111152, 2021.
C. Williams, Weaver, L. K., Langford, D., Lindblad, A., and Wierzbicki, M. R., Neurological Evaluations within the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA), in Undersea and Hyperbaric Medical Society Annual Scientific Meeting; Military Health System Research Symposium, 2014.
S. D. Williams, Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., and Spaulding, J. T., Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer., N Engl J Med, vol. 317, no. 23, pp. 1433-8, 1987.
A. D. Williams, Grantz, K. L., Zhang, C., Nobles, C., Sherman, S., and Mendola, P., Ambient Volatile Organic Compounds and Racial/Ethnic Disparities in Gestational Diabetes Mellitus: Are Asian/Pacific Islander Women at Greater Risk?, Am J Epidemiol, vol. 188, no. 2, pp. 389-397, 2019.
T. Williams, Blumberg, D., Perdue, L., Woolard, N., and Moreno, O., Incorporating Web-based Training Tools and Technology in Clinical Trials Training, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
R. F. Willkens and Stablein, D., Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial., J Rheumatol Suppl, vol. 44, pp. 64-8, 1996.
R. F. Willkens, Sharp, J. T., Stablein, D., Marks, C., and Wortmann, R., Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment., Arthritis Rheum, vol. 38, no. 12, pp. 1799-806, 1995.
J. R. Wingard, Carter, S. L., Walsh, T. J., Kurtzberg, J., Small, T. N., Baden, L. R., Gersten, I. D., Mendizabal, A. M., Leather, H. L., Confer, D. L., Maziarz, R. T., Stadtmauer, E. A., Bolaños-Meade, J., Brown, J., Dipersio, J. F., Boeckh, M., and Marr, K. A., Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation., Blood, vol. 116, no. 24, pp. 5111-8, 2010.
J. Wingard, Carter, S., Walsh, T., Kurtzberg, J., Small, T., Baden, L., Gersten, I., Mendizabal, A., Leather, H., Confer, D., Maziarz, R., Stadtmauer, E., Bolanos-Meade, J., Brown, J., DiPersio, J., Boeckh, M., and Marr, K., Randomized Double-blind Trial of Fluconazole vs Voriconazole for Prevention of Invasive Fungal Infection after Allo Hematopoietic Cell Transplantation, Blood, vol. 116, pp. 5111-5118, 2010.
T. M. Winhusen, Stitzer, M. L., Woody, G. E., Brigham, G. S., Kropp, F. B., Ghitza, U., Lindblad, R., Adinoff, B., Green, C., Sharma, G., and Somoza, E., Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-Dependent Individuals, Contemp Clin Trials, vol. 33, pp. 197-205, 2012.
T. Winhusen, Stitzer, M., Woody, G., Brigham, G., Kropp, F., Ghitza, U., Lindblad, R., Adinoff, B., Green, C., Sharma, G., and Somoza, E., Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals., Contemp Clin Trials, vol. 33, no. 1, pp. 197-205, 2012.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence., J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
T. Winhusen, Lewis, D., Sharma, G., and Sparenborg, S., A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence, in College on Problems of Drug Dependence Meeting, San Juan, Puerto Rico, 2014.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., VanVeldhuisen, P., Adinoff, B., and Somoza, E., Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world., Contemp Clin Trials, vol. 33, no. 5, pp. 993-1002, 2012.
T. Winhusen, Lofwall, M., Jones, H. E., Wilder, C., Lindblad, R., Schiff, D. M., Wexelblatt, S., Merhar, S., Murphy, S. M., Greenfield, S. F., Terplan, M., Wachman, E. M., Kropp, F., Theobald, J., Lewis, M., Matthews, A. G., Guille, C., Silverstein, M., and Rosa, C., Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations., Contemp Clin Trials, vol. 93, p. 106014, 2020.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence, J Clin Psychiatry, vol. 75, pp. 757-764, 2014.
T. Winhusen, Brady, K. T., Stitzer, M., Woody, G., Lindblad, R., Kropp, F., Brigham, G., Liu, D., Sparenborg, S., Sharma, G., Van Veldhuisen, P., Adinoff, B., and Somoza, E., Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
P. L. Winokur, Chaloner, K., Doem, G. V., Ferreira, J., and Apicella, M. A., Safety and Immunological Outcomes Following Human Inoculation with Nontypeable Haemophilus Influenzae, J Infect Dis, vol. 208, pp. 728-738, 2013.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older., Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
P. L. Winokur, Patel, S. M., Brady, R., Chen, W. H., El-Kamary, S. S., Edwards, K., Creech, C. B., Frey, S., Keitel, W. A., Belshe, R., Walter, E., Bellamy, A., Hill, H., and Group, T. V. T. E. U. - H. 3Nv, Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine, J Infect Dis, vol. 212, pp. 525-530, 2015.
P. L. Winokur, Chaloner, K., Doern, G. V., Ferreira, J., and Apicella, M. A., Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae., J Infect Dis, vol. 208, no. 5, pp. 728-38, 2013.
J. S. Wittenborn, Clemons, T., Regillo, C., Rayess, N., Kruger, D. Liffmann, and Rein, D., Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System., JAMA Ophthalmol, vol. 135, no. 5, pp. 452-459, 2017.